Oligo Synthesis : CEPs
Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.
Cis-syn Thymine Dimer Phosphoramidite
Cis-syn Thymine Dimer Phosphoramidite
Glen Research
| Catalogue No. | Description | Pack Size | Price | Qty |
|
|---|---|---|---|---|---|
| 11-1330-02 | Cis-syn Thymine Dimer Phosphoramidite | 0.25g | £10,000.00£7,752.00Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
| 11-1330-90 | Cis-syn Thymine Dimer Phosphoramidite | 100µmoles | £4,112.00£3,192.00Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
| 11-1330-95 | Cis-syn Thymine Dimer Phosphoramidite | 50µmoles | £2,064.00£1,596.00Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
Cis-syn Thymine Dimer Phosphoramidite
Cis-syn Thymine Dimer Phosphoramidite
Glen Research
| Cis-syn Thymine Dimer Phosphoramidite |
Catalog Number: 11-1330-xx
Description: Cis-syn Thymine Dimer Phosphoramidite
| 5"-Dimethoxytrityl-2"-deoxy-5,6-dihydro-Thymidine-(cis-syn-cyclobutanyl)-5"->3"-(methyl-phosphoryl)-2"-deoxy-5,6-dihydro-Thymidine-3"-[methyl-(N,N-diisopropyl)]-phosphoramidite | ||
| Formula: C49H63N5O15P2 | M.W.: 1024.01 | F.W.: 608.39 |
Diluent: Anhydrous Acetonitrile |
| Coupling: 10 minute coupling recommended. |
| Deprotection: 1.Remove the methyl phosphate groups by treating the support with thiophenol/triethylamine/THF (1:2:2) v/v/v for 45 minutes at room temperature.Wash the support with THF 1X, methanol 5X, acetonitrile 3X and dry with air or argon.2.Cleave and deprotect the oligo in the dark with ammonium hydroxide at room temperature under conditions appropriate to remove the protecting groups on the nucleobases. |
| Storage: Freezer storage, -10 to -30°C, dry |
| Stability in Solution: 2-3 days |
STRUCTURE/ACTIVITY RELATIONSHIP
The following products are used to investigate the effect on theactivity of an oligonucleotide when key structural elements are changed. The7-deaza purine monomers lack groups critical for hydrogen bonding.7-Deaza-8-aza-A and 7-deaza-8-aza-G (PPG) monomers are isomers of A and G andhave similar electron density. Their presence in oligos is slightly stabilizingrelative to A and G. Unlike G, PPG does not lead to aggregation and G-richoligos can be easily prepared and isolated. 5’-Fluorescein oligos with PPG atthe 5’-terminus are much less quenched than the equivalent G oligos. As a purineanalogue of Thymidine, 7-deaza-2’-deoxyXanthosine (7-deaza-dX) promises to haveinteresting effects on DNA structure of triplexes. 7-Deaza-dX also forms anon-standard base pair with a 2,4-diaminopyrimidine nucleoside analogue.Standard nucleobases have an unshared pair of electrons that project into the minor groove of duplex DNA. Enzymes that interact with DNA,polymerases, reverse transcriptases, restriction enzymes, etc., may use ahydrogen bond donating group to contact the hydrogen bond acceptor in the minorgroove. 3-Deaza-2’-deoxyadenosine is very interesting in that it maintains theability for regular Watson-Crick hydrogen bonding to T but is lacking theelectron pair at the 3-position normally provided by N3.
One of the major sources of DNA damage in all organisms is the UV component ofsunlight. The predominant reaction induced by UV light on DNA is dimerization ofadjacent pyrimidine bases leading to cyclobutane dimers (CPDs). The dimersformed in the most significant quantity are the cis-syn cyclobutane dimer of twothymine bases. Although formed routinely, these dimer products are efficientlyexcised and repaired enzymatically (nucleotide excision repair) or thedimerization is reversed by photolase enzymes. These lesions have been connectedto the formation of squamous cell carcinomas. In addition, humans who lackability to repair CPD lesions with high efficiency may be geneticallypredisposed to Xeroderma Pigmentosa (XP), a disease characterized by extremesensitivity to sunlight and high frequency of skin cancer. Polymerasesencountering unrepaired CPD lesions are quite error-prone, leading to incorrectbase insertions and subsequent mutations.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
Cis-syn Thymine Dimer Phosphoramidite
Cis-syn Thymine Dimer Phosphoramidite
Glen Research
Material Safety Data Sheet
Glen Report 16.2: Thymine dimers - DNA lesions induced by sunlight cis-syn thymine dimer phosphoramidite now available
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
Cis-syn Thymine Dimer Phosphoramidite
Cis-syn Thymine Dimer Phosphoramidite
Glen Research
DILUTION/COUPLING DATA
The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.
| ABI 392/394 | |||||||||
| Cat.No. | PackSize | Grams/Pack | 0.1M Dil.(mL) | LV40 | LV200 | 40nm | 0.2µm | 1µm | 10µm |
| Approximate Number of Additions | |||||||||
| 11-1330-02 | 0.25grams | .25grams | 2.44 | 68 | 40.8 | 25.5 | 18.55 | 13.6 | 3.4 |
| 11-1330-90 | 100µmoles | .102grams | 1 | 20 | 12 | 7.5 | 5.45 | 4 | 1 |
| 11-1330-95 | 50µmoles | .051grams | .5 | 3.33 | 2 | 1.25 | .91 | .67 | .17 |
| Expedite | |||||||||
| Cat.No. | PackSize | Grams/Pack | Dilution(mL) | Molarity | 50nm | 0.2µm | 1µm | 15µm | |
| Approximate Number of Additions | |||||||||
| 11-1330-02 | 0.25grams | .25grams | 3.64 | .07 | 66.4 | 41.5 | 30.18 | 4.15 | |
| 11-1330-90 | 100µmoles | .102grams | 1.5 | .07 | 23.6 | 14.75 | 10.73 | 1.48 | |
| 11-1330-95 | 50µmoles | .051grams | .75 | .07 | 8.6 | 5.38 | 3.91 | .54 | |
| Beckman | |||||||||
| Cat.No. | PackSize | Grams/Pack | Dilution(mL) | Molarity | 30nm | 200nm | 1000nm | ||
| Approximate Number of Additions | |||||||||
| 11-1330-02 | 0.25grams | .25grams | 3.64 | .07 | 68 | 42.5 | 30.91 | ||
| 11-1330-90 | 100µmoles | .102grams | 1.5 | .07 | 25.2 | 15.75 | 11.45 | ||
| 11-1330-95 | 50µmoles | .051grams | .75 | .07 | 10.2 | 6.38 | 4.64 | ||
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
AthensResearch&Technology公司位于美国乔治亚州雅典市，从1986年以来一直致力于纯化高纯度，高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白，血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来，世界各地的研究人员都在使用我们公司的产品。在炎症、冠状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。我们提供优质，可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务，AthensResearch&Technology公司能够根据您的项目要求提供无与伦比的试剂。
公司主要产品：一、凝血因子相关系列产品：包括多款从人血浆、血小板中分离纯化的凝血因子相关蛋白。二、酶及抑制剂系列产品：包括多款从人血浆、红细胞分离纯化的a-抗糜蛋白酶、a1/2抗胰蛋白酶、抗凝血酶、C1酯酶抑制因子、Calpain-1等酶及其抑制剂产品。三、免疫球蛋白系列产品：包括多款从人血浆、骨髓瘤、初乳以及狗和小鼠血浆中分离纯化的免疫球蛋白产品。四、脂蛋白及载脂蛋白系列产品：包括包括多款从人血浆中分离纯化的载脂蛋白及脂蛋白（高密度、中等密度、低密度、极低密度脂蛋白）产品。五、低内毒素蛋白系列产品：包括多款适宜于细胞培养的低内毒素脂蛋白、免疫球蛋白及转铁蛋白产品。六、乳蛋白系列产品：包括从人乳中分离纯化的乳白蛋白、乳铁传递蛋白及分泌型免疫球蛋白A。七、中性粒细胞源蛋白系列产品：包括多款纯化分离自人中性粒细胞的Azurocidin 、CathepsinG及Lactoferrin等蛋白产品。八、血小板相关系列产品：包括纯化分离自人血小板的血小板因子4及凝血酶致敏蛋白。九、转铁蛋白及脱铁转铁蛋白（APOTRANSFERRINS）系列产品：包括多款纯化分离自人、大小鼠、狗及食蟹猴血浆中的转铁蛋白/脱铁转铁蛋白，可应用于细胞或组织培养。十、抗体系列产品：包括多款兔、大鼠、羊源的多克隆抗体产品。
ebiomall.com
